Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Amortizatization of Intangibles (2022 - 2023)

Lexeo Therapeutics' Amortizatization of Intangibles history spans 2 years, with the latest figure at $79000.0 for Q4 2023.

  • For Q4 2023, Amortizatization of Intangibles rose 118.29% year-over-year to $79000.0; the TTM value through Dec 2023 reached $306000.0, changed N/A, while the annual FY2024 figure was $325000.0, 6.21% up from the prior year.
  • Amortizatization of Intangibles for Q4 2023 was $79000.0 at Lexeo Therapeutics, roughly flat from $79000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $321000.0 in Q1 2023 and bottomed at -$432000.0 in Q4 2022.